CytoMed Therapeutics Ltd. () Stock Analysis | Price, Returns, Financials & Key Metrics

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

10.77 k

Shareholding (Dec 2024)

FII

0.09%

Held by 1 FIIs

DII

99.91%

Held by 0 DIIs

Promoter

0.00%

How big is CytoMed Therapeutics Ltd.?

22-Jun-2025

As of Jun 18, CytoMed Therapeutics Ltd. has a market capitalization of 26.36 million, with net sales of 461.62 million and a net profit of -26.88 million over the latest four quarters. The company reported shareholder's funds of 6.57 million and total assets of 7.38 million as of Dec 24.

What does CytoMed Therapeutics Ltd. do?

22-Jun-2025

CytoMed Therapeutics Ltd. is a micro-cap company in the Pharmaceuticals & Biotechnology industry, with recent net sales of $98 million and a net profit loss of $10 million. The company has a market cap of $26.36 million and does not pay dividends.

Is CytoMed Therapeutics Ltd. technically bullish or bearish?

25-Jun-2025

As of June 20, 2025, CytoMed Therapeutics Ltd. is in a bearish trend with moderate strength, indicated by bearish MACD, Bollinger Bands, moving averages, and KST across various timeframes.

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Dashboard

Unrated Stock - No Analysis Available

Mojo Parameters

Stock DNA

Industry

Pharmaceuticals & Biotechnology

Market cap

USD 21 Million ()

P/E

NA (Loss Making)

Industry P/E

Dividend Yield

0.00%

Debt Equity

-0.51

Return on Equity

-999,999.00%

Price to Book

3.27

Revenue and Profits:

Net Sales:

98 Million

(Quarterly Results - Apr 2017)

Net Profit:

-10 Million

Total Returns

Total Returns (Price + Dividend)

TimePeriod

Price Return

Dividend Return

Total Return

3 Months

-26.87%

6 Months

-22.25%

1 Year

-38.75%

2 Years

-52.41%

3 Years

0.0%

4 Years

0.0%

5 Years

0.0%

CytoMed Therapeutics Ltd. for the last several years.

Risk Adjusted Returns v/s

News & Corporate Actions

News

No Recent News for the Company

Announcements

No announcement available

Corporate Actions

No corporate action available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

-1.35%

EBIT Growth (5y)

-245.93%

EBIT to Interest (avg)

-2.11

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

-0.51

Sales to Capital Employed (avg)

131.50

Tax Ratio

0.73%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

0.14%

ROCE (avg)

ROE (avg)

Valuation key factors

Factor

Value

P/E Ratio

NA (Loss Making)

Industry P/E

Price to Book Value

3.91

EV to EBIT

-1.14

EV to EBITDA

-1.86

EV to Capital Employed

6.89

EV to Sales

0.05

PEG Ratio

Dividend Yield

ROCE (Latest)

-606.40%

ROE (Latest)

-409.03%

Technicals key factors

Indicator

Weekly

Monthly

MACD

Bearish

RSI

No Signal

Bollinger Bands

Mildly Bearish

Bearish

Moving Averages

Bearish (Daily)

KST

Mildly Bullish

Dow Theory

No Trend

Mildly Bullish

OBV

No Trend

Mildly Bearish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot : Dec 2024

Shareholding Compare (%holding)

Majority shareholders

Foreign Institutions

Domestic Funds

Held in 0 Schemes (0%)

Foreign Institutions

Held by 1 Foreign Institutions (0.09%)

Strategic Entities with highest holding

Highest Public shareholder

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Apr'17 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Apr 2017 is -6.85% vs -18.02% in Apr 2016",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Apr 2017 is -51.56% vs -3,100.00% in Apr 2016",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Apr'17",
        "Apr'16",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "97.90",
          "val2": "105.10",
          "chgp": "-6.85%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-7.50",
          "val2": "-4.70",
          "chgp": "-59.57%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "2.10",
          "val2": "1.70",
          "chgp": "23.53%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-9.70",
          "val2": "-6.40",
          "chgp": "-51.56%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "0.00%",
          "val2": "0.00%",
          "chgp": "NA",
          "chgp_class": "neutral"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'23",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2023 is 0.00% vs 0.00% in Dec 2022",
        "dir": 0
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2023 is -34.78% vs -53.33% in Dec 2022",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'23",
        "Dec'22",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-3.10",
          "val2": "-1.60",
          "chgp": "-93.75%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.10",
          "chgp": "-100.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-0.30",
          "val2": "-0.80",
          "chgp": "62.50%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-3.10",
          "val2": "-2.30",
          "chgp": "-34.78%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "0.00%",
          "val2": "0.00%",
          "chgp": "NA",
          "chgp_class": "neutral"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Apr'17 - YoY

Apr'17

Apr'16

Change(%)

Net Sales

97.90

105.10

-6.85%

Operating Profit (PBDIT) excl Other Income

-7.50

-4.70

-59.57%

Interest

2.10

1.70

23.53%

Exceptional Items

0.00

Consolidate Net Profit

-9.70

-6.40

-51.56%

Operating Profit Margin (Excl OI)

0.00%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in quarter ended Apr 2017 is -6.85% vs -18.02% in Apr 2016

Consolidated Net Profit

YoY Growth in quarter ended Apr 2017 is -51.56% vs -3,100.00% in Apr 2016

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'23

Dec'23

Dec'22

Change(%)

Net Sales

0.00

Operating Profit (PBDIT) excl Other Income

-3.10

-1.60

-93.75%

Interest

0.00

0.10

-100.00%

Exceptional Items

-0.30

-0.80

62.50%

Consolidate Net Profit

-3.10

-2.30

-34.78%

Operating Profit Margin (Excl OI)

0.00%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2023 is 0.00% vs 0.00% in Dec 2022

Consolidated Net Profit

YoY Growth in year ended Dec 2023 is -34.78% vs -53.33% in Dec 2022

All Annual Results

Company CV

About CytoMed Therapeutics Ltd.

CytoMed Therapeutics Ltd.

Pharmaceuticals & Biotechnology

No Details Available.

Company Coordinates

No Company Details Available

CytoMed Therapeutics Ltd.

1Day

52 Week

CASH

FII

DII

Promoter

How big is CytoMed Therapeutics Ltd.?

Watch in Real-Time

What does CytoMed Therapeutics Ltd. do?

Is CytoMed Therapeutics Ltd. technically bullish or bearish?

MarketsMojo — Loved in India, Now Global

Dashboard

Mojo Parameters

Stock DNA

Total Returns (Price + Dividend)

Risk Adjusted Returns v/s

News

Announcements

Corporate Actions

Quality key factors

Valuation key factors

Technicals key factors

Shareholding Snapshot : Dec 2024

Shareholding Compare (%holding)

Quarterly Results Snapshot (Consolidated) - Apr'17 - YoY

Annual Results Snapshot (Consolidated) - Dec'23

About CytoMed Therapeutics Ltd.

Company Coordinates